Category Archives: MS Treatment

ARLINGTON, Texas (AP) Mike Napoli's three-run homer put the Texas Rangers ahead to stay. The catcher also blocked the plate to prevent a run and was in sync with pitcher Matt Harrison all night. Not a bad all-around effort. Nelson Cruz added a homer of his own and two outfield assists, combining with Napoli to deny Brendan Ryan an inside-the-park homer in the eighth inning, and Texas beat the Seattle Mariners 4-2 on Monday night. ''That was awesome,'' said Harrison, who tossed eight strong innings. Napoli and Cruz homered before Michael Saunders singled in the eighth for Seattle. Ryan followed with a liner to right-center that bounced over the glove of a diving Craig Gentry and rolled to the wall. While Saunders scored easily, Cruz ran down the ball and threw to second baseman Ian Kinsler, who made a perfect relay to the plate. Napoli tagged out the sliding Ryan. ''I'm never going to forget that as long as I live,'' Ryan said. ''I don't even know where to start with that. ... I never had the opportunity before. Loss aside and all that, it would have been pretty sweet. Kind of a baseball bucket list thing.'' Except Ryan never … Continue reading →

Select a Publication: N E W S P A P E R S ---------------------------------------------- ---Alberta--- Airdrie - Airdrie Echo Banff - Banff Crag and Canyon Beaumont - Beaumont News Calgary - The Calgary Sun Camrose - Camrose Canadian Canmore - Canmore Leader Central Alberta - County Market Cochrane - Cochrane Times Cold Lake - Cold Lake Sun Crowsnest Pass - Crowsnest Pass Promoter Devon - Dispatch News Drayton - Drayton Valley Western Review Edmonton - Edmonton Examiner Edmonton - The Edmonton Sun Edson - Edson Leader Fairview - Fairview Post Fort McMurray - Fort McMurray Today Fort Saskatchewan - Fort Saskatchewan Record Grande Prairie - Daily Herald Tribune Hanna - Hanna Herald High River - High River Times Hinton - Hinton Parklander Lacombe - Lacombe Globe Leduc - Leduc Representative Lloydminster - Meridian Booster Mayerthorpe - Mayerthorpe Freelancer Nanton - Nanton News Peace Country - Peace Country Sun Peace River - Peace River Record Gazette Pincher Creek - Pincher Creek Echo Sherwood Park - Sherwood Park News Spruce Grove - Spruce Grove Examiner Stony Plain - Stony Plain Reporter Strathmore - Strathmore Standard Vermilion - Vermilion Standard Vulcan - Vulcan Advocate Wetaskiwin - Wetaskiwin Times Whitecourt - Whitecourt Star ---Manitoba--- … Continue reading →

Select a Publication: N E W S P A P E R S ---------------------------------------------- ---Alberta--- Airdrie - Airdrie Echo Banff - Banff Crag and Canyon Beaumont - Beaumont News Calgary - The Calgary Sun Camrose - Camrose Canadian Canmore - Canmore Leader Central Alberta - County Market Cochrane - Cochrane Times Cold Lake - Cold Lake Sun Crowsnest Pass - Crowsnest Pass Promoter Devon - Dispatch News Drayton - Drayton Valley Western Review Edmonton - Edmonton Examiner Edmonton - The Edmonton Sun Edson - Edson Leader Fairview - Fairview Post Fort McMurray - Fort McMurray Today Fort Saskatchewan - Fort Saskatchewan Record Grande Prairie - Daily Herald Tribune Hanna - Hanna Herald High River - High River Times Hinton - Hinton Parklander Lacombe - Lacombe Globe Leduc - Leduc Representative Lloydminster - Meridian Booster Mayerthorpe - Mayerthorpe Freelancer Nanton - Nanton News Peace Country - Peace Country Sun Peace River - Peace River Record Gazette Pincher Creek - Pincher Creek Echo Sherwood Park - Sherwood Park News Spruce Grove - Spruce Grove Examiner Stony Plain - Stony Plain Reporter Strathmore - Strathmore Standard Vermilion - Vermilion Standard Vulcan - Vulcan Advocate Wetaskiwin - Wetaskiwin Times Whitecourt - Whitecourt Star ---Manitoba--- … Continue reading →

24 May 2012 Last updated at 20:02 ET Researchers are carrying out clinical trials to find out if women with a range of autoimmune diseases could be helped by hormones found in pregnancy. Women with a range of conditions, including multiple sclerosis, rheumatoid arthritis and thyroid disease report dramatic improvements in their symptoms during pregnancy. However many say their conditions return, or worsen, after childbirth. Two clinical trials are being held in France and California. Researchers want to find out whether increasing levels of progesterone or oestrogen could protect women from relapses after childbirth. The MS Society has welcomed the study but urged some caution. Chief executive Simon Gillespie said: "This is encouraging. Some of the research going on, particularly the research in France at the moment, gives a potential clue and a potential way forward on treatments but long-term use of hormones is problematic. It does cause risks. "So therefore the research needs to be done properly to identify what the benefits are and what the risks are before there can be any genuine therapeutic use." The results from the French study are due in October. Read the rest here: MS symptoms 'eased' by pregnancy … Continue reading →

The volatile salts, ammonium acetate and ammonium formate are utilized in LC/MS applications to improve ionization under neutral conditions in ESI-MS, while acetic acid enhances chromatography separation under acidic conditions. These new Optima LC/MS reagents have minimal metal ion content, which limits mass adduct formation, facilitating MS interpretation. In addition, the low impurity levels, confirmed by diode array detection (LC/UV), extend column life. Purity is further enhanced by a new proprietary surface treatment applied to the HDPE bottle for acetic acid, which acts as a barrier between the bottle and acid, preventing contamination by plasticizers. Acetic acid is also available in convenient, ready to use 1mL glass ampules, ensuring the freshest additive for preparing aqueous and organic mobile phases in seconds, while safely eliminating the need to measure corrosive acids. To ensure optimum quality, product uniformity and purity, the ultrapure Optima LC/MS solvent range is manufactured in ISO 9001:2008 certified facilities. Lot-to-lot consistency and high purity across the entire Optima range, including the three new reagents, ensure consistent high standards during LC/MS applications and reproducible results with extremely low background noise. For more information on the Optima LC/MS reagents range and other Fisher Chemical products please visit http://www.acros.com or contact … Continue reading →

OTTAWA A member of an expert group advising the Canadian Institutes of Health Research (CIHR) about the effectiveness of a controversial treatment for multiple sclerosis has likened it to faith healing. Dr. Barry Rubin, medical director of the Toronto General Hospital's cardiac centre, and three American co-authors draw the parallel in an article entitled "The 'Liberation Procedure' for Multiple Sclerosis: Sacrificing Science at the Altar of Consumer Demand," in the current issue of the Journal of the American College of Radiology. Rubin sits on the CIHR's Scientific Expert Working Group, a 23-member international panel created by CIHR in 2010 to monitor and analyse research into the link between MS and chronic cerebrospinal venous insufficiency (CCSVI), a term coined by Italian doctor Paolo Zamboni to describe blockages in the veins of the neck and spine. Zamboni's so-called "liberation treatment" involves opening the blocked veins by inserting a balloon, a procedure known as venous angioplasty. Health Minister Leona Aglukkaq announced last month a team of researchers has been selected to conduct a clinical trial into CCSVI in about 100 MS patients. But the article by Rubin and his three co-authors says funding trials of a procedure "that has minimal basis in rational, … Continue reading →

TAIPEI, Taiwan--(BUSINESS WIRE)-- After returning to Vietnam, Ms. Nguyen Thi Ngoc Mai is blossoming with smiles, thanks to a group of people from Taiwan that have given her new perspective on life. Ms. Nguyen Thi Ngoc Mai, a 28-year-old Vietnamese patient struck with a rare aging disease that made her look like a 70-year-old lady, came to Taiwan for medical treatment. She began showing signs of Werner syndrome at the age of ten. But lacking the financial means to obtain medical assistance, her only option was the use of local herbs available in her home village. By the time she arrived in Taiwan, she looked and walked like a 70-year-old lady. After intensive treatment, she seems to be given a new perspective on life. It is hard to describe in words, but after seeing her transformation, all the hard work is worth it, said Mr. Walter Yeh, Vice President of Taiwan External Trade Development, while attending the press conference held in Ho Chi Minh City, Vietnam. Mr. Yeh led the medical team from China Medical University Hospital, Taiwan, and Ms. Nguyen Thi Ngoc Mai, accompanied by Ms. Nguyens brother, back to Vietnam. Mr. Yeh expressed the importance of this occasion, … Continue reading →

SAN DIEGO, May 14 (UPI) -- Smoking marijuana may be an effective treatment for spasticity -- a common and disabling symptom of multiple sclerosis, U.S. researchers suggest. Principal investigator Dr. Jody Corey-Bloom, professor of neurosciences and director of the Multiple Sclerosis Center at the University of California, San Diego, and colleagues randomly assigned 30 study participants to either the intervention group -- which smoked marijuana once daily for three days -- or the control group. After an 11-day interval, the participants crossed over to the other group. "We found that smoked cannabis was superior to placebo in reducing symptoms and pain in patients with treatment-resistant spasticity, or excessive muscle contractions," Corey-Bloom said in a statement. The researchers used a modified Ashford scale to grade the intensity of muscle tone by measuring such things as resistance in range of motion and rigidity. The researchers also looked at physical performance -- using a timed walk -- and cognitive function. Patients were also asked assess their feeling of "highness." The study published in the Canadian Medical Association Journal found the marijuana was generally well tolerated, but it has mild effects on attention and concentration. The researchers noted that larger, long-term studies were needed … Continue reading →

The U.S. Food & Drug Administration (FDA) just issued a warning alert that a multiple sclerosis (MS) stent treatment is both unproven and potentially deadly. Health care professionals and patients are being warned about injuries and deaths linked to use of an experimental procedure, sometimes referred to as liberation therapy or liberation procedure, used in the treatment of chronic cerebrospinal venous insufficiency (CCSVI). CCSVI is characterized by a narrowing (stenosis) of veins in the neck and chest; some experts believe that CCSVI is precursor or contributor to MS, impairing brain and upper spinal cord blood drainage. The experimental procedure uses balloon angioplasty devices or stents to widen narrowed chest and neck veins; however, the agency has been advised of incidents of death, stroke, stent detachment and migration, damage to the treated vein, blood clots, cranial nerve damage, and abdominal bleeding linked to the experimental procedure. Specifically, the FDA announced that at least two people died from the experimental procedure, said Reuters. Another patient is now permanently paralyzed, and others suffered bleeding in the brain, suffered strokes, blood clots, or other side effects. Stents are steel mesh coils that prop open arteries; balloon angioplasties utilize a balloon at the tip of … Continue reading →

The liberation therapy for MS targets chronic cerebrospinal venous insufficiency. (File photo) Food and Drug Administration (FDA) authorities have warned that an experimental treatment for multiple sclerosis (MS) called "liberation therapy" has no proven benefit and may even cause death. The FDA has issued a warning saying that using the unproven treatment for MS patients has caused death, strokes, nerve damage and abdominal bleeding. The unproven treatment targets chronic cerebrospinal venous insufficiency (CCSVI) or narrowing of the veins in the head and neck that is often linked to MS. The procedure includes widening narrowed veins in the chest and neck through the use of balloon angioplasty or stents. Both of the techniques are commonly used to treat the blocked or narrowed coronary arteries of the heart. "Because there is no reliable evidence from controlled clinical trials that this procedure is effective in treating MS, FDA encourages rigorously-conducted, properly-targeted research to evaluate the relationship between CCSVI and MS, the federal agency recommended in a statement. Patients are encouraged to discuss the potential risks and benefits of this procedure with a neurologist or other physician who is familiar with MS and CCSVI, including the CCSVI procedures and their outcomes," the statement added. … Continue reading →